Boston Scientific (BSX) Gross Profit Growth (1y) (2010 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | 15.59% |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | 21.17% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 13.68% |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 17.10% |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | 12.38% |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | 13.54% |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | 20.68% |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 20.50% |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | 8.95% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 3.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.38% |
| Mar 31, 2026 | 12.59% |
| Dec 31, 2025 | 18.87% |
| Sep 30, 2025 | 22.26% |
| Jun 30, 2025 | 20.14% |
| Mar 31, 2025 | 21.22% |
| Dec 31, 2024 | 20.01% |
| Sep 30, 2024 | 19.41% |
| Jun 30, 2024 | 12.12% |
| Mar 31, 2024 | 12.73% |
| Dec 31, 2023 | 15.55% |
| Sep 30, 2023 | 10.73% |
| Jun 30, 2023 | 13.84% |
| Mar 31, 2023 | 13.42% |
| Dec 31, 2022 | 3.57% |
| Sep 30, 2022 | 7.82% |
| Jun 30, 2022 | 4.74% |
| Mar 31, 2022 | 11.46% |
| Dec 31, 2021 | 26.17% |
| Sep 30, 2021 | 13.52% |